The aim of the present investigation was to evaluate the effect of a synthetic peptide, corresponding to a sequence which differs between the alfa and alfa’ subunits from 7S soy globulin, on cell cholesterol homeostasis both in HepG2 cells and in rats fed casein-cholesterol diet. Hep G2 cells were incubated for 24 hr in minimum essential medium (MEM) + 5% LPDS in the presence/absence of whole 7S globulin (0.5 mg/mL) or its alfa’ subunit (0.125 mg/mL) or the synthetic peptide (10-5 M and 10-6 M). Cell preincubation with whole 7S soy globulin caused an increase in the mature forms of SREBP-1, both in membranes (+ 90%) and in nuclei (+ 130%), vs that found in the control Hep G2 cells (MEM + 5% LPDS). Moreover, a lower level of mature nuclear SREBP-1 was detected in Hep G2 cells exposed to the alfa’ subunit compared to that found after exposure to whole 7S globulin. Hep G2 cells exposed to the synthetic peptide, at concentration of 10-5 M and 10-6 M, showed an increased 125I-LDL uptake (+ 38% and + 42%, respectively) and degradation (+46% and +53%, respectively) vs values recorded in non exposed cells; a dose-dependent increase in the SREBP2 mRNA and LDL-receptor mRNA was detected by RT-PCR in the same cell line exposed to the synthetic peptide (10-5 M and 10-6 M). The oral administration (14 days) of synthetic peptide (5 mg/Kg b.w.) to casein-cholesterol fed rats resulted in lower plasma lipid levels (cholesterol, -25%; triglycerides, −28%) vs values recorded in rats fed casein-cholesterol diet alone. These results represent the first in vivo evidence of the plasma lipid-lowering properties induced by the synthetic peptide in an animal model of human hypercholesterolemia. Supported in part by a grant from MIUR of Italy